111 related articles for article (PubMed ID: 1651982)
1. Protective immunity against bovine leukaemia virus (BLV) induced in carrier sheep by inoculation with a vaccinia virus-BLV env recombinant: association with cell-mediated immunity.
Ohishi K; Suzuki H; Yamamoto T; Maruyama T; Miki K; Ikawa Y; Numakunai S; Okada K; Ohshima K; Sugimoto M
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1887-92. PubMed ID: 1651982
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of bovine leukemia virus (BLV)-specific lymphocyte proliferation responses in ruminants by inoculation with BLV env-recombinant vaccinia virus: their role in the suppression of BLV replication.
Ohishi K; Suzuki H; Yasutomi Y; Onuma M; Okada K; Numakunai S; Ohshima K; Ikawa Y; Sugimoto M
Microbiol Immunol; 1992; 36(12):1317-23. PubMed ID: 1337572
[TBL] [Abstract][Full Text] [Related]
3. Protection of sheep against bovine leukemia virus (BLV) infection by vaccination with recombinant vaccinia viruses expressing BLV envelope glycoproteins: correlation of protection with CD4 T-cell response to gp51 peptide 51-70.
Gatei MH; Naif HM; Kumar S; Boyle DB; Daniel RC; Good MF; Lavin MF
J Virol; 1993 Apr; 67(4):1803-10. PubMed ID: 7680387
[TBL] [Abstract][Full Text] [Related]
4. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
5. Involvement of CD8+ T cells in delayed-type hypersensitivity responses against bovine leukemia virus (BLV) induced in sheep vaccinated with recombinant vaccinia virus expressing BLV envelope glycoprotein.
Okada K; Ikeyama S; Ohishi K; Suzuki H; Sugimoto M; Numakunai S; Chiba T; Murakami K; Davis WC; Ohshima K
Vet Pathol; 1993 Mar; 30(2):104-10. PubMed ID: 8470333
[TBL] [Abstract][Full Text] [Related]
6. Role of cell-mediated immunity in bovine leukemia virus (BLV) infection in ruminants: its implication for the vaccination strategy against retroviruses.
Sugimoto M; Ohishi K; Ikawa Y
Ther Immunol; 1994 Oct; 1(5):297-301. PubMed ID: 7584504
[TBL] [Abstract][Full Text] [Related]
7. Induction of neutralizing antibodies against bovine leukosis virus in rabbits by vaccination with recombinant vaccinia virus expressing bovine leukosis virus envelope glycoprotein.
Ohishi K; Suzuki H; Maruyama T; Yamamoto T; Funahashi S; Miki K; Ikawa Y; Sugimoto M
Am J Vet Res; 1990 Aug; 51(8):1170-3. PubMed ID: 2167028
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of a recombinant vaccinia virus expressing envelope a glycoprotein of bovine leukaemia virus.
Ohishi K; Maruyama T; Shida H; Nishimaki J; Miki K; Sagata N; Ikawa Y; Sugimoto M
Vaccine; 1988 Oct; 6(5):428-32. PubMed ID: 2848378
[TBL] [Abstract][Full Text] [Related]
9. Recombinant viral vaccines for enzootic bovine leucosis.
Daniel RC; Gatei MH; Good MF; Boyle DB; Lavin MF
Immunol Cell Biol; 1993 Oct; 71 ( Pt 5)():399-404. PubMed ID: 8270269
[TBL] [Abstract][Full Text] [Related]
10. Viral status and antibody response in cattle inoculated with recombinant bovine leukemia virus-vaccinia virus vaccines after challenge exposure with bovine leukemia virus-infected lymphocytes.
Cherney TM; Schultz RD
Am J Vet Res; 1996 Jun; 57(6):812-8. PubMed ID: 8725805
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated immunity to BLV replication: analogous to HIV immunopathogenesis?
Sugimoto M; Ohishi K; Ikawa Y
Immunol Today; 1993 Apr; 14(4):190-1. PubMed ID: 8388695
[No Abstract] [Full Text] [Related]
12. Protective vaccination against bovine leukaemia virus infection by means of cell-derived vaccine.
Altaner C; Ban J; Altanerova V; Janik V
Vaccine; 1991 Dec; 9(12):889-95. PubMed ID: 1667347
[TBL] [Abstract][Full Text] [Related]
13. An effective peptide vaccine to eliminate bovine leukaemia virus (BLV) infected cells in carrier sheep.
Kabeya H; Ohashi K; Ohishi K; Sugimoto C; Amanuma H; Onuma M
Vaccine; 1996 Aug; 14(12):1118-22. PubMed ID: 8911007
[TBL] [Abstract][Full Text] [Related]
14. [Protective effect against BLV by inoculation with a vaccinia virus-BLV env recombinant].
Ohishi K
Uirusu; 1992 Dec; 42(2):155-70. PubMed ID: 1338242
[No Abstract] [Full Text] [Related]
15. Protection of cattle against bovine leukemia virus (BLV) infection could be attained by DNA vaccination.
Brillowska A; Dabrowski S; Rułka J; Kubiś P; Buzała E; Kur J
Acta Biochim Pol; 1999; 46(4):971-6. PubMed ID: 10824867
[TBL] [Abstract][Full Text] [Related]
16. T cell-mediated destruction of bovine leukemia virus-infected peripheral lymphocytes by bovine leukemia virus env-vaccinia recombinant vaccine.
Ohishi K; Ikawa Y
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):393-8. PubMed ID: 8882317
[No Abstract] [Full Text] [Related]
17. gammadelta(+) T-Lp6phocyte cytotoxicity against envelope-expressing target cells is unique to the alymphocytic state of bovine leukemia virus infection in the natural host.
Lundberg P; Splitter GA
J Virol; 2000 Sep; 74(18):8299-306. PubMed ID: 10954528
[TBL] [Abstract][Full Text] [Related]
18. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
19. Peptide-based bovine leukemia virus (BLV) vaccine that induces BLV-Env specific Th-1 type immunity.
Ohishi K; Kabeya H; Amanuma H; Onuma M
Leukemia; 1997 Apr; 11 Suppl 3():223-6. PubMed ID: 9209348
[TBL] [Abstract][Full Text] [Related]
20. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]